Evidence map›Paper›PMID 24708306›Full record

ArticleMolecular pharmaceutics2014

In vivo performance of a novel fluorinated magnetic resonance imaging agent for functional analysis of bile acid transport.

Diana Vivian, Kunrong Cheng, Sandeep Khurana, Su Xu, Edwin H Kriel, Paul A Dawson, Jean-Pierre Raufman, James E Polli

Open access · bronzeAbstract read
In one paragraph

Article in Molecular pharmaceutics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Novel nitroxide-bile acid conjugates inform substrate requirements for human bile acid transporters.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2023
    Article
  3. Review
  4. Review
  5. Review
  6. AMagma (New York, N.Y.) · 2019
    Review
  7. Attenuated Accumulation of Novel Fluorine (Molecular pharmaceutics · 2018
    Article
  8. A novel bioluminescence-based method to investigate uptake of bile acids in living cells.American journal of physiology. Gastrointestinal and liver physiology · 2018
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Diana VivianDepartment of Pharmaceutical Sciences, University of Maryland School of Pharmacy , Baltimore, Maryland 21230, United States.
Kunrong Cheng
Sandeep Khurana
Su Xu
Edwin H Kriel
Paul A Dawson
Jean-Pierre Raufman
James E Polli
University of Maryland, Baltimore · USWake Forest University · US

Funding

Research Training in Gastroenterology and HepatologyT32DK067872 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI RAUFMAN, JEAN-PIERRE · 2005 to 2024
$7.2M
ILEAL BILE ACID TRANSPORTER METABOLISM AND REGULATIONR01DK047987 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI DAWSON, PAUL A · 2000 to 2021
$6.8M
Role of M3 muscarinic receptors in bile acid-induced colon cancerR01CA120407 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI RAUFMAN, JEAN-PIERRE · 2008 to 2011
$1.2M
Mechanisms of Vascular Dysfunction in CirrhosisK08DK081479 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI KHURANA, SANDEEP · 2008 to 2012
$716k
Creating a toolkit to measure in vivo bile acid transportR21DK093406 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI POLLI, JAMES E, RAUFMAN, JEAN-PIERRE · 2012 to 2013
$404k
ILEAL BILE ACID TRANSPORTER METABOLISM AND REGULATIONR29DK047987 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI DAWSON, PAUL A · 1994 to 1998
–
NCI NIH HHS CA-120407NIDDK NIH HHS DK047987NIDDK NIH HHS DK-067872NIDDK NIH HHS DK-081479NIDDK NIH HHS DK-093406NIDDK NIH HHS K08 DK081479NIDDK NIH HHS R01 DK047987NIDDK NIH HHS R21 DK093406NIDDK NIH HHS R29 DK047987NIDDK NIH HHS T32 DK067872
6 · The paper itself

Abstract

A novel trifluorinated cholic acid derivative, CA-lys-TFA, was designed and synthesized for use as a tool to measure bile acid transport noninvasively using magnetic resonance imaging (MRI). In the present study, the in vivo performance of CA-lys-TFA for measuring bile acid transport by MRI was investigated in mice. Gallbladder CA-lys-TFA content was quantified using MRI and liquid chromatography/tandem mass spectrometry. Results in wild-type (WT) C57BL/6J mice were compared to those in mice lacking expression of Asbt, the ileal bile acid transporter. (19)F signals emanating from the gallbladders of WT mice 7 h after oral gavage with 150 mg/kg CA-lys-TFA were reproducibly detected by MRI. Asbt-deficient mice administered the same dose had undetectable (19)F signals by MRI, and gallbladder bile CA-lys-TFA levels were 30-fold lower compared to WT animals. To our knowledge, this represents the first report of in vivo imaging of an orally absorbed drug using (19)F MRI. Fluorinated bile acid analogues have potential as tools to measure and detect abnormal bile acid transport by MRI.

Indexed as

AnimalsBile Acids and SaltsBiological TransportChromatography, LiquidGallbladderMagnetic Resonance ImagingMaleMiceMice, Inbred C57BLTandem Mass SpectrometryBile Acids and Salts

Identifiers

PMID24708306
PMCPMC4018118
OpenAlexW2312266342

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.